<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
#f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff5; src: url("5.otf"); }
#f1 { font-family:ff5,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.otf"); }
#f2 { font-family:ff4,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff6; src: url("6.otf"); }
#f3 { font-family:ff6,sans-serif; font-weight:normal; font-style:italic; }
@font-face { font-family: ff13; src: url("13.otf"); }
#f4 { font-family:ff13,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff11; src: url("11.otf"); }
#f5 { font-family:ff11,monospace; font-weight:normal; font-style:normal; }
@font-face { font-family: ff12; src: url("12.otf"); }
#f6 { font-family:ff12,monospace; font-weight:bold; font-style:normal; }
</style>
</head>
<body>
<img id="background" style="position:absolute; left:0px; top:0px;" width="585" height="783" src="page7.png">
<div class="txt" style="position:absolute; left:42px; top:41px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">Cryo-EM Structure of </span><span id="f3" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">A. baumannii </span><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">Efﬂux Pump</span></div>
<div class="txt" style="position:absolute; left:41px; top:72px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">V612, and F615 form a hydrophobic patch and have the highest impact on drug</span></div>
<div class="txt" style="position:absolute; left:41px; top:84px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">binding (36). It appears that these four amino acids contribute to the stabilization of</span></div>
<div class="txt" style="position:absolute; left:41px; top:97px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">almost all bound substrates. The corresponding four AdeB residues are F178, F277, I607,</span></div>
<div class="txt" style="position:absolute; left:41px; top:109px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">and W610, which also create a hydrophobic patch (Fig. 3C). It is possible that this</span></div>
<div class="txt" style="position:absolute; left:41px; top:121px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">hydrophobic patch is important for AdeB-drug interactions.</span></div>
<div class="txt" style="position:absolute; left:53px; top:133px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">The crystal structure of AcrB-minocycline indicates that Q176, F178, N274, F615, and</span></div>
<div class="txt" style="position:absolute; left:41px; top:145px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">F617 directly contact the bound minocycline to secure the binding at the distal site (19).</span></div>
<div class="txt" style="position:absolute; left:41px; top:158px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">In AdeB, these residues are Q176, F178, A274, W610, and F612. Two of these residues</span></div>
<div class="txt" style="position:absolute; left:41px; top:170px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">(F178 and W610) participate in forming the hydrophobic patch. These residues may</span></div>
<div class="txt" style="position:absolute; left:41px; top:182px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">also be critical for AdeB-drug interactions at the distal binding site. It should be noted</span></div>
<div class="txt" style="position:absolute; left:41px; top:194px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">that our cryo-EM structure should represent the apo-AdeB conformation, as there is no</span></div>
<div class="txt" style="position:absolute; left:41px; top:207px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">trace of extra density found in either the proximal or distal multidrug binding site.</span></div>
<div class="txt" style="position:absolute; left:53px; top:219px;"><span id="f2" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">Docking of substrates into the multidrug binding sites. </span><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">Alignment of the AdeB</span></div>
<div class="txt" style="position:absolute; left:41px; top:231px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">protein sequences from different strains of </span><span id="f3" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">A. baumannii </span><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">suggests that these proteins</span></div>
<div class="txt" style="position:absolute; left:41px; top:243px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">possess </span><span id="f4" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">Ͼ</span><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">99% identity (Fig. 4). Of the 1,035 residues of AdeB, only eight amino acids</span></div>
<div class="txt" style="position:absolute; left:41px; top:256px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">are not conserved among these protein sequences. The nonconserved residues are not</span></div>
<div class="txt" style="position:absolute; left:41px; top:268px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">located near the multidrug binding sites. Thus, they may not be important for the</span></div>
<div class="txt" style="position:absolute; left:41px; top:280px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">speciﬁcity and function of these pumps.</span></div>
<div class="txt" style="position:absolute; left:53px; top:293px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">To understand how AdeB is capable of accommodating a variety of antibiotics, we</span></div>
<div class="txt" style="position:absolute; left:41px; top:305px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">used the program AutoDock Vina (39) to elucidate the potential drug-binding modes.</span></div>
<div class="txt" style="position:absolute; left:41px; top:317px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">We chose tigecycline, imipenem, ciproﬂoxacin, erythromycin, and gentamicin, as they</span></div>
<div class="txt" style="position:absolute; left:41px; top:329px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">are known ligands of AdeB, which mediates resistance to these antibiotics (12, 40, 41).</span></div>
<div class="txt" style="position:absolute; left:41px; top:341px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">When Vina was employed to search for possible binding sites of these drugs in the</span></div>
<div class="txt" style="position:absolute; left:41px; top:354px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">periplasmic domain of AdeB, it was found that all of these drug molecules were bound</span></div>
<div class="txt" style="position:absolute; left:41px; top:366px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">within the periplasmic entrance, as well as the proximal and distal multidrug binding</span></div>
<div class="txt" style="position:absolute; left:41px; top:378px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">sites (Fig. 5). The predicted binding afﬁnities for these antibiotics are listed in Table 2.</span></div>
<div class="txt" style="position:absolute; left:53px; top:390px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">As both </span><span id="f3" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">A. baumannii </span><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">AdeB and </span><span id="f3" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">P. aeruginosa </span><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">MexY are capable of mediating</span></div>
<div class="txt" style="position:absolute; left:41px; top:402px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">resistance to aminoglycosides, we decided to study the similarity of these two efﬂux</span></div>
<div class="txt" style="position:absolute; left:41px; top:415px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">pumps. Protein sequence alignment suggests that AdeB and MexY only share 46%</span></div>
<div class="txt" style="position:absolute; left:41px; top:427px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">identity. Apparently, these two proteins are quite different in terms of the amino acid</span></div>
<div class="txt" style="position:absolute; left:41px; top:439px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">composition. However, a detailed investigation indicates that these two efﬂux proteins</span></div>
<div class="txt" style="position:absolute; left:41px; top:451px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">may have a similar substrate speciﬁcity. For example, our docking study showed that</span></div>
<div class="txt" style="position:absolute; left:41px; top:464px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">F277 and W610 of AdeB may be important for contact with the gentamicin molecule</span></div>
<div class="txt" style="position:absolute; left:41px; top:476px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">at the distal drug-binding site. The corresponding two amino acids in the MexY pump</span></div>
<div class="txt" style="position:absolute; left:41px; top:488px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">are F276 and F610, which are also aromatic residues with similar characteristics.</span></div>
<div class="txt" style="position:absolute; left:41px; top:500px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">Docking of gentamicin to the proximal drug-binding site of AdeB suggests that</span></div>
<div class="txt" style="position:absolute; left:41px; top:512px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">residues Y77, T91, and S134 may be essential for interacting with this drug molecule.</span></div>
<div class="txt" style="position:absolute; left:41px; top:525px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">These corresponding residues in MexY are Y77, T90, and S134, which are conserved</span></div>
<div class="txt" style="position:absolute; left:41px; top:537px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">between these two multidrug efﬂux pumps. Similarly, within the periplasmic entrance,</span></div>
<div class="txt" style="position:absolute; left:41px; top:549px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">our docking study shows that E563 of AdeB may be an important residue for anchoring</span></div>
<div class="txt" style="position:absolute; left:41px; top:561px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">gentamicin. The corresponding MexY residue is E563, suggesting that this glutamate</span></div>
<div class="txt" style="position:absolute; left:41px; top:573px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">may be critical for recognizing aminoglycoside drugs in the MexY pump.</span></div>
<div class="txt" style="position:absolute; left:53px; top:586px;"><span id="f2" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">Proton relay network. </span><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">Drug extrusion via RND efﬂux pumps is driven by proton</span></div>
<div class="txt" style="position:absolute; left:41px; top:598px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">motive force. In the transmembrane region of AdeB, D407, D408, K931, and T968 are</span></div>
<div class="txt" style="position:absolute; left:41px; top:611px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">conserved amino acids within the proton relay network (Fig. 6). They are most probably</span></div>
<div class="txt" style="position:absolute; left:41px; top:623px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">responsible for proton translocation and energy coupling. Interestingly, a nearby</span></div>
<div class="txt" style="position:absolute; left:41px; top:635px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">conserved polar residue, N932, is found to interact with K931. The side-chain oxygen of</span></div>
<div class="txt" style="position:absolute; left:41px; top:647px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">N932 is 2.7 Å away from the side-chain nitrogen of K931, participating in the formation</span></div>
<div class="txt" style="position:absolute; left:41px; top:659px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">of a hydrogen bond (Fig. 6A). It is likely that this residue is also involved in the proton</span></div>
<div class="txt" style="position:absolute; left:41px; top:672px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">relay network.</span></div>
<div class="txt" style="position:absolute; left:53px; top:684px;"><span id="f2" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">Proposed mechanism of proton transfer in the proton relay network of AdeB.</span></div>
<div class="txt" style="position:absolute; left:41px; top:696px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">Based on the available structural information of HAE-RND efﬂux pumps, including AcrB</span></div>
<div class="txt" style="position:absolute; left:41px; top:708px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">and CmeB, we hypothesize that the inﬂux of protons and efﬂux of drugs are synchro-</span></div>
<div class="txt" style="position:absolute; left:41px; top:720px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">nized and coupled with each other (Fig. 7). In the absence of toxic compounds, the</span></div>
<div class="txt" style="position:absolute; left:41px; top:732px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">pump may remain in the resting state, such that there is no proton transfer via the</span></div>
<div class="txt" style="position:absolute; left:41px; top:752px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">July/August 2019 Volume 10 Issue 4 e01295-19</span></div>
<div class="txt" style="position:absolute; left:540px; top:38px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">®</span></div>
<div class="txt" style="position:absolute; left:492px; top:752px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">mbio.asm.org </span><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">7</span></div>
</body>
</html>
